Navigation Links
Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections

FREDERICK, Md., April 30 /PRNewswire/ -- Royer Animal Health, LLC, a wholly owned subsidiary of Royer Biomedical, Inc., has executed an exclusive distribution agreement with MWI Veterinary, Supply, Inc. (Nasdaq: MWIV) to market its lead animal health products: MATRIX III CISPLATIN BEADS and R-GEL ANTIBIOTIC WOUND DRESSING. These proprietary, timed-release products provide veterinary professionals with localized treatment options for cancer, infections, and general wound management.

By providing locally controlled delivery and increased drug concentration, Royer Animal Health therapies have proven to be highly effective, with no systemic side effects. These innovative products have only recently become available, they are currently being used in over 600 veterinary clinics and by 40 veterinary schools / teaching hospitals worldwide.

MATRIX III CISPLATIN BEADS have been clinically proven highly effective in the treatment of certain cancers with tumor rates of less than 10% reported. These fully-resorbable, [3 mm] Cisplatin Bead implants are indicated for use in the local control of equine sarcoids; clinical studies have also shown the effective use of Matrix III Cisplatin Beads in other tumor types including: melanoma, squamous cell, carcinoma and osteosarcoma. The product is safe, easy to use and manufactured under FDA -compliant conditions and represent a major breakthrough in cost-effective veterinary chemotherapy."

R-GEL ANTIBIOTIC WOUND DRESSING, is a timed-release antibiotic gel that solidifies in situ. It provides a sustained therapeutic dose of amikacin and clindamycin at the site of administration for a period of 7-9 days. The R-GEL matrix is biodegradable and fully resorbed in about 4 weeks. R-GEL has proven to be highly effective in the treatment of a wide range of small and large animal indications including: contaminated wounds, dental abscesses, deep lacerations, bite wounds, necrotic tissue, infected tendon sheaths, septic joints, post-operative orthopedic infections and hoof abscesses.

Supplied in a dual-syringe Kit for easy administration, R-GEL is available in both a 2ml and a 4 ml dose.

Dr. Gar Royer, President and CEO of Royer Animal Health, commented: "We are very pleased to be entering into this relationship with MWI, and believe that many new practitioners, as well as their patients and clients will benefit from the positive outcomes that will result by using our innovative products."

Royer Animal Health, LLC has developed novel superior products utilizing proprietary drug delivery technologies. Our mission is to provide veterinary professional with localized drug delivery products providing increased drug concentration to the targeted site versus systemic delivery, and consequently enhanced efficacy, without systemic side effects. Both Matrix III and R-Gel drug delivery matrices, are bio-resorbable, and have the ability to provide an effective, controlled release of drugs over a broad range of time spans. For more information about Royer Animal Health, please visit our website at

MWI is a distributor of animal health products to veterinarians across the United States. MWI sells pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, veterinary pet food and nutritional products. They market these products to veterinarians in both the companion animal and production animal markets. For more information about MWI, please visit our website at

For more information contact: Steve Kirschner at 301.696.2177

SOURCE Royer Animal Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nasal Anthrax Vaccine Proves Effective in Animal Study
2. Molecular probe paints cancer cells in living animals, Stanford researchers find
3. USC researcher identifies stem cells in tendons that regenerate tissue in animal model
4. UCSF animal care facility receives top accreditation
5. Why are some groups of animals so diverse?
6. Penn Veterinary Medicine report new strategy to create genetically modified animals
7. ABC TV San Francisco Features Canine Cancer Research Story: Saving Our Dogs, Helping Humans Beat Cancer - Work at Morris Animal Foundation, UC-Davis
8. Scientists get first look at nanotubes inside living animals
9. Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies
10. Fort Dodge Animal Health and the American Association of Feline Practitioners Launch Educational Web Site for Cat Owners -
11. American Humane Association Adds Direct Services in Animal-Assisted Activities and Therapy
Post Your Comments:
(Date:11/28/2015)... ... 2015 , ... Pixel Film Studios is back again with ProPanel: Pulse ... are endless. Users have full control over angle of view, speed method, start point, ... sure to get heads to turn. , ProPanel: Pulse offers fully customizable pulsating shape ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... University of Toronto and the University of British Columbia suggested that laws requiring bicyclists ... The article explains that part of the reason for the controversial conclusion is that, ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors ... treat it. Surviving Mesothelioma has just posted the findings on the website. Click ... analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed by ...
(Date:11/27/2015)... ... ... Lizzie’s Lice Pickers just announced a special promotion that will run throughout ... of lice treatment product. In addition, customers will receive a complimentary head Check when ... is a sure way to ruin the holidays, so we encourage all of our ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community ... 30 (see Table 1-1 ). More than 3.7 billion people under the age ... type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . , ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
(Date:11/26/2015)... --> ... att använda SyMRI för att hitta optimal ... med multipel skleros (MS) eller hjärntumörmetastaser och ... för att kunna använda SyMRI Research Edition ... kan man generera flera konstrastbilder från en ...
Breaking Medicine Technology: